Fibrates

Fibrates are a class of prescription medications used to improve unhealthy lipid or cholesterol levels in the blood. They are mainly prescribed for people with high triglycerides (a type of fat in your blood) or certain types of dyslipidemia that increase the risk of heart disease and pancreatitis.

Unlike statins, which primarily target LDL cholesterol, fibrates focus on lowering triglyceride levels and raising HDL cholesterol, often called “good” cholesterol. In some patients, fibrates may be used alone, while in others they are combined carefully with statins under close healthcare supervision.

Fibrates, also called fibric acid derivatives or fibrate medications, are lipid-lowering drugs used to treat high cholesterol and lipid levels in the blood. They are most often prescribed for hypertriglyceridemia (high triglyceride levels) and mixed dyslipidemia.

Fibrates work differently from statins and other cholesterol-lowering medications. Their main goal is to reduce triglyceride levels, lower very-low-density lipoproteins (VLDL), and increase levels of high-density lipoprotein (HDL). Because of these effects, fibrates play a specific role in managing cardiovascular disease risk in selected patients.

The mechanism of action of fibrates involves activating specific proteins in the body called peroxisome proliferator-activated receptors, specifically PPAR-alpha. These receptors help regulate how the body processes fats.

When fibrates activate PPAR-alpha, several beneficial changes occur in lipid metabolism. They increase the activity of lipoprotein lipase, an enzyme that breaks down triglycerides in the blood. This leads to lower triglyceride levels and reduced levels of very-low-density lipoproteins.

Fibrates also affect fatty acids and bile acid metabolism, helping reduce the production of triglycerides in the liver. At the same time, they increase high-density lipoprotein and HDL cholesterol by boosting the production of proteins involved in HDL formation. These combined effects of fibrates help improve overall lipid levels and slow the progression of atherosclerosis.

There are several fibrates available, though only a few are commonly used in routine healthcare. These medications are taken by mouth and are usually dosed once or twice daily, depending on the drug.

Common fibrates include:

• Fenofibrate (Tricor).

• Gemfibrozil (Lopid).

• Bezafibrate (Bezalip).

Fenofibrate is the most frequently prescribed fibrate in the United States. Gemfibrozil is effective but is used less often with statins due to a higher risk of muscle-related side effects. Bezafibrate is used in some countries and has similar lipid-lowering effects.

Fibrates are mainly used to treat lipid disorders involving high triglycerides. They are often prescribed for hypertriglyceridemia and mixed dyslipidemia when triglyceride levels remain high despite lifestyle changes.

Key uses of fibrates include:

Lowering high triglycerides, which reduces the risk of pancreatitis.

Raising HDL cholesterol in people with low HDL levels.

Improving lipid profiles in people with metabolic syndrome or type 2 diabetes.

Fibrates may also be used in people with hyperlipidemia or hypercholesterolemia when triglycerides are the main concern rather than LDL cholesterol. In some cases, fibrates are combined with statins, such as simvastatin, but this requires careful monitoring due to an increased risk of muscle toxicity.

By improving triglyceride and HDL levels, fibrates may help reduce long-term cardiovascular disease risk, although their effect on preventing heart attack and coronary heart disease is more selective than statins.

Fibrates can cause side effects, though many people tolerate them well. The risk and severity of side effects depend on the specific medication, dose, and whether fibrates are combined with other lipid-lowering drugs.

Common side effects seen in clinical trials include:

Upset stomach or abdominal discomfort.

Nausea or diarrhea.

Headache.

Mild muscle pain.

More serious but less common side effects of fibrates include gallstones, liver enzyme elevations, and muscle problems. When fibrates are taken with statins, especially gemfibrozil, there is a higher risk of muscle pain, rhabdomyolysis, and muscle toxicity.

Fibrates may also affect kidney function in some people, particularly those with existing kidney disease. These are known side effects of fibrates, but not everyone will experience them.

These are not all of the possible side effects of Fibrates. You should always seek medical advice from your healthcare provider for any questions or concerns about your medical condition or treatment. Read all patient information, medication guides, or drug information sheets that come with this medication. You can also report adverse effects to the Food and Drug Administration at www.fda.gov/medwatch or 1-800-FDA-1088.

Although these medications are generally well-tolerated and safe, there are certain warnings, precautions, and drug interactions you should be aware of.

Warnings

Before starting Fibrates, it is crucial to discuss any existing health conditions with your healthcare provider. You should be sure that your healthcare provider is aware of all your medical conditions, including:

Kidney disease.

Liver disease.

Gallbladder disease or a history of gallstones.

Muscle disorders or a history of statin-related muscle pain.

People with insulin resistance, type 2 diabetes, or metabolic syndrome may benefit from fibrates, but careful monitoring is still required.

Contraindications

Fibrates are generally not recommended for people with severe kidney disease, active liver disease, or gallbladder disease. They should also be avoided in people with known hypersensitivity to fibric acid derivatives.

Drug interactions

When Fibrates is taken with other prescription drugs, over-the-counter medications, vitamins, and supplements, it may change how they work or increase the frequency or severity of side effects. Make sure that you tell your healthcare professional about anything that you are taking to avoid any negative drug interactions, including:

Statins increase the risk of muscle toxicity.

Blood thinners may require dose adjustments.